Replies to post #106755 on Anavex Life Sciences Corp (AVXL)

[frrol]

Yes, appears so

[kld2]

OFP, what's your take on the PK/PD analysis? Why do you think it's taking so long? It's been 9 months since the announcement of a collaboration between Anavex and Ariana (Oct. 5, 2016 pr). In Missling's Noble presentation he emphasized, several times, its importance; obviously determining subgroups in trial protocol is essential. I mean, we aren't talking about many patients; Missling seemed to focus on the 6-7 super-responders. What's the hold-up?

http://www.anavex.com/anavex-life-sciences-and-ariana-pharma-collaborate-to-accelerate-timelines-and-improve-efficiency-of-alzheimers-and-parkinsons-clinical-development-programs/